Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung Disease

NCT05177471 · clinicaltrials.gov ↗
WITHDRAWN
Status
OTHER
Sponsor class

Stopped no eligible patients

Conditions

Sponsor

Central Hospital, Nancy, France